表柔比星辅助化疗在老年恶性淋巴瘤治疗中的临床研究

打开文本图片集

【摘 要】目的：探讨老年恶性淋巴瘤，选择表柔比星辅助化疗方案的效果及价值。方法：选100例老年恶性淋巴瘤患者为研究对象，抽签分两组，各50例。对照组给予常规化疗；观察组给予表柔比星辅助化疗；对比两组相关指标、并发症发生率、治疗效果。结果：两组相比，观察组血小板计数、白细胞计数、血红蛋白指标、并发症发生率均低于对照组（P

【关键词】恶性淋巴瘤；表柔比星；化疗；血小板、白细胞；并发症；治疗效果

Clinical study of epirubicin adjuvant chemotherapy in the treatment of Senile Malignant Lymphoma

YANG Yang

Meishan Hospital of traditional Chinese medicine， Meishan， Sichuan 620000， China

【Abstract】Objective： To explore the effect and value of malignant lymphoma and choose adjuvant chemotherapy in the elderly.Methods： 100 elderly patients with malignant lymphoma were selected for 50 each.The control group was given conventional chemotherapy； the observation group gave adjuvant chemotherapy with epirubicin； and compared the relevant indicators， incidence of complications and treatment effect between the two groups.Results： Compared to the two groups， the platelet count， leukocyte count， hemoglobin index， and complication incidence were lower than the control group（P

【Key？Words】Malignant lymphoma； epirubicin； chemotherapy； platelets， white blood cells； complications； treatment effect

恶性淋巴瘤为非霍奇金淋巴瘤，依据病理类型分为T细胞、B细胞、NK细胞淋巴瘤，临床表现为颈部出现包块，可随病情发展逐渐变大，患者还会出现盗汗、发热等症状[1]。（剩余3254字）